BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
-
* Corresponding author: Thomas Reithmeier thomas.reithmeier@uniklinik-freiburg.de
BMC Cancer 2010, 10:30 doi:10.1186/1471-2407-10-30
Accesses
- Last 30 days: 232 accesses
- Last 365 days: 2170 accesses
- All time: 5202 accesses